Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Xavier Aldeguer"'
Autor:
Montse Capdevila, Jesús Garcia-Gil, Anna Bahí, Joan Amoedo, Mariona Serra-Pagès, Miriam Sàbat, David Busquets, Jordi Guardiola, Xavier Aldeguer, Marta Malagón, L Peries, Rosa Chavero, Sara Ramió-Pujol, Marta Serrano, Pau Gilabert, Leyanira Torrealba, Aleix Lluansí, Lia Oliver
Publikováno v:
Inflammatory bowel diseases. 27(Suppl 2)
Background and Aims Crohn’s disease and ulcerative colitis evolve with alternate outbreaks and remissions of variable duration in both cases. Despite the advances, about 10-30% of patients do not respond to the treatment after the induction period.
Autor:
J O Miquel-Cusachs, Antoni Castells, Xavier Queralt-Moles, Anna Bahí, Lia Oliver, Pau Gilabert, Jordi Guardiola, Virginia Piñol, Manel Ramirez, L. Jesús Garcia-Gil, Joan Saló, Xavier Aldeguer, Mariona Serra-Pagès, Marta Serrano, Joan Amoedo, Marta Malagón, Sara Ramió-Pujol
Publikováno v:
PLoS One, 2020, vol. 15, núm. 12, p. e0243158
Articles publicats (D-B)
Malagón Rodríguez, Marta Ramió Pujol, Sara Serrano, Marta Amoedo, Joan Oliver, Lia Bahí, Anna Miquel Cusachs, Josep Oriol Ramírez, Manel Queralt Moles, Xavier Gilabert, Pau Saló, Joan Guardiola, Jordi Piñol Sánchez, Virgínia Serra Pagès, Mariona Castells, Antoni Aldeguer i Manté, Xavier Garcia-Gil, L. J. 2020 New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population PLoS One 15 12 e0243158
DUGiDocs – Universitat de Girona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0243158 (2020)
PLoS ONE
Articles publicats (D-B)
Malagón Rodríguez, Marta Ramió Pujol, Sara Serrano, Marta Amoedo, Joan Oliver, Lia Bahí, Anna Miquel Cusachs, Josep Oriol Ramírez, Manel Queralt Moles, Xavier Gilabert, Pau Saló, Joan Guardiola, Jordi Piñol Sánchez, Virgínia Serra Pagès, Mariona Castells, Antoni Aldeguer i Manté, Xavier Garcia-Gil, L. J. 2020 New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population PLoS One 15 12 e0243158
DUGiDocs – Universitat de Girona
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0243158 (2020)
PLoS ONE
Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270f9f289880df742de405b2cc8c932
http://hdl.handle.net/10256/18762
http://hdl.handle.net/10256/18762
Autor:
Sara Ramió-Pujol, Jesús Garcia-Gil, Leyanira Torrealba Medina, Ariadna Clos, Eugeni Domènech, David Busquets, Joan Amoedo, Miriam Sàbat, Míriam Mañosa, Pau Gilabert, J.Oriol Miquel-Cusachs, Anna Bahí, Jordi Guardiola, Mariona Serra-Pagès, C Puig-Amiel, Xavier Aldeguer, Lia Oliver, Fiorella Cañete
Publikováno v:
Gastroenterology. 158:S-696
Autor:
J.Oriol Miquel-Cusachs, Jordi Guardiola, Xavier Aldeguer, Sara Ramió-Pujol, Lia Oliver, Joan Saló, Pau Gilabert, Marta Malagón, Marta Serrano, Joan Amoedo, Mariona Serra-Pagès, Virginia Piñol, Anna Bahí, Antoni Castells, Jesús Garcia-Gil
Publikováno v:
Gastroenterology. 158:S-772
Autor:
J Amoedo Cibeira, Jesús Garcia-Gil, David Busquets, Mariona Serra-Pagès, J O Miquel-Cusachs, Anna Bahí, Xavier Aldeguer, Sara Ramió-Pujol, Lia Oliver
Publikováno v:
Journal of Crohn's and Colitis. 14:S653-S653
Background Inflammatory bowel disease (IBD) is defined as a group of autoimmune diseases that affects the digestive tract by causing chronic inflammatory processes. Crohn’s disease (CD) is one of the major types of IBD. Although there are several e
Autor:
Marta Malagón, Jordi Guardiola, Laura García-Nimo, Joaquín Cubiella, Leyanira Torrealba, Joan Amoedo, Pau Gilabert, J O Miquel-Cusachs, Virginia Piñol, Marta Serrano, Sara Ramió-Pujol, Teresa Mas-de-Xaxars, Mariona Serra-Pagès, Jesús Garcia-Gil, Joan Saló, Anna Bahí, Antoni Castells, Xavier Aldeguer, Lia Oliver
Publikováno v:
Alimentary pharmacologytherapeutics. 49(11)
Background Colorectal cancer is the second commonest cause of cancer mortality. Some countries are implementing colorectal cancer screening to detect lesions at an early stage using non-invasive tools like the faecal immunochemical test. Despite affo
Autor:
M. Malagόn, Xavier Aldeguer, David Busquets, Jesús Garcia-Gil, Joan Amoedo, Anna Bahí, Marta Serrano, Jordi Guardiola, Mariona Serra-Pagès, Pau Gilabert
Publikováno v:
Journal of Crohn's and Colitis. 11:S148-S149
Autor:
Stephan R. Vavricka, Laurent Peyrin-Biroulet, Morten H. Vatn, Robert Logan, Kenneth Nally, Alain M. Schoepfer, Xavier Aldeguer, Gerhard Rogler, Ulrich Mittmann, Wolfgang Kruis, Anders Lasson
Publikováno v:
Journal of Crohn's & colitis
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2013, 7 (8), pp.670-677. ⟨10.1016/j.crohns.2013.02.014⟩
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2013, 7 (8), pp.670-677. ⟨10.1016/j.crohns.2013.02.014⟩
International audience; Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD) are organic inflammatory diseases, caused by chronic mucosal inflammation of the intestine. They are typically characterized by variab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54638796c0e43060adfde08bff3c4fe
https://doi.org/10.5167/uzh-92852
https://doi.org/10.5167/uzh-92852